Tag: IgAN

FDA Grants Traditional Approval to First Complement Inhibitor for Primary IgA Nephropathy

The US FDA has granted traditional approval to Novartis' Fabhalta® (iptacopan), the…

ME Desk

Novartis’ Fabhalta gets FDA nod for IgAN Treatment

Basel- August 2024- Novartis announced that the U.S. Food and Drug Administration…

ME Desk